
Vobligo 0.3mg Tablet
Marketer
Pharma Corp Inc Pvt Ltd
Salt Composition
Voglibose (0.3mg)
Overview Vobligo 0.3mg Tablet
Vobiglin 0.3mg tablets are prescribed for managing type 2 diabetes. This medication aids in post-meal blood glucose regulation, employed when dietary adjustments and other similar treatments prove insufficient. Administer Vobiglin 0.3mg immediately before meals; dosage and frequency are determined by your physician to optimize blood sugar control. Discontinuing this medication abruptly is strongly discouraged without consulting your doctor, as it may elevate blood glucose, potentially leading to severe complications such as renal impairment or vision loss. This medication forms part of a comprehensive treatment plan encompassing a healthy diet, regular physical activity, and weight management as directed by your healthcare provider. Regular blood glucose monitoring is crucial during treatment. Commonly reported side effects include abdominal discomfort, gas, appetite changes, constipation, and diarrhea. Report any persistent or bothersome side effects to your doctor. While Vobiglin 0.3mg itself rarely causes hypoglycemia, concomitant use with other diabetes medications (particularly insulin or sulfonylureas) may increase this risk. Treat hypoglycemic episodes with plain glucose; sucrose is ineffective in this context. Inform your doctor of any pre-existing liver or kidney conditions before commencing treatment. Avoid Vobiglin 0.3mg if you have bowel inflammation or ulceration (e.g., Crohn's disease or ulcerative colitis). Pregnant or lactating individuals should seek medical advice before use. Always disclose all other medications you are taking to ensure medication safety. Limit alcohol consumption while using this medication to minimize the hypoglycemia risk.
Uses of Vobligo 0.3mg Tablet
Managing type 2 diabetes
Major Benefits of Vobligo 0.3mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the entire tablet without chewing, crushing, or fracturing it. Administer Vobligo 0.3mg Tablet on an empty stomach.
Common Side effects of Vobligo 0.3mg Tablet:
- Skin rash
- Flatulence
- Abdominal pain
- Diarrhea
How to use Vobligo 0.3mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the entire tablet without chewing, crushing, or fracturing it. Administer Vobligo 0.3mg Tablet on an empty stomach.
How Vobligo 0.3mg Tablet works:
Omniglyc 0.3mg tablets are used to manage diabetes. They work by blocking enzymes in the gut that digest complex carbohydrates into simple sugars like glucose, thus moderating post-meal blood sugar spikes.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while taking Vobligo 0.3mg tablets is unsafe.
PregnancySAFE IF PRESCRIBED
The use of Vobligo 0.3mg tablets during pregnancy is typically deemed safe. Preclinical trials in animals have revealed minimal or no negative consequences for fetal development; however, data from human trials are scarce.
Breast feedingSAFE IF PRESCRIBED
Breastfeeding mothers can likely use Vobligo 0.3mg tablets without significant risk to their infants. Available human data indicates minimal infant hazard from this medication.
DrivingSAFE
Driving ability is typically unaffected by Vobligo 0.3mg tablets.
KidneyCAUTION
Exercise caution when administering 0.3mg Vobligo tablets to individuals with significant renal impairment. Dosage modification of Vobligo 0.3mg tablets may be necessary. Physician consultation is advised.
LiverCAUTION
Patients with severe hepatic impairment should use Vobligo 0.3mg tablets cautiously. Dosage modification of Vobligo 0.3mg tablets may be necessary. Physician consultation is advised.
What if you forget to take Vobligo 0.3mg Tablet :
Omit any missed Vobligo 0.3mg Tablet dose and resume your regular dosing regimen. Avoid taking a double dose.
Facts to Know About Vobligo 0.3mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Valiolamine analog |
| Developing Habits | No. |
| Type of Therapy | Diabetes Medication |
| Actions | Alpha-glucosidase inhibitors |
